GHK-Cu

Mechanism of action in research models

Collagen and ECM synthesis: GHK-Cu has been documented to upregulate collagen type-I synthesis in human fibroblast cultures, with studies reporting 3–7-fold increases in procollagen secretion versus vehicle-treated controls. Mechanistically, this is associated with increased TGF-β1 secretion by fibroblasts in response to GHK-Cu exposure — TGF-β1 then acts in autocrine/paracrine manner to activate SMAD2/3-mediated collagen gene transcription. GHK-Cu also upregulates elastin, fibronectin, and the proteoglycan decorin in ECM-composition studies.

Metalloproteinase regulation: a key feature of GHK-Cu’s ECM research profile is its differential regulation of MMPs. It upregulates MMP-2 (gelatinase A) and MMP-9 in research models — enzymes that degrade damaged collagen and basement membrane — while simultaneously stimulating TIMP-1 and TIMP-2 expression. This coordinated MMP/TIMP induction is characteristic of controlled ECM remodelling rather than simple degradation or synthesis.

Angiogenesis: GHK-Cu stimulates VEGF expression in fibroblasts and endothelial cells, promotes endothelial-cell migration in scratch-wound assays, and increases capillary tube formation in Matrigel-based angiogenesis assays. VEGF induction has been partially attributed to copper’s role as a cofactor for HIF-1α stability — suggesting the GHK-Cu complex activates the HIF-1α/VEGF angiogenic axis.

Antioxidant and anti-inflammatory effects: GHK-Cu activates the Nrf2/ARE antioxidant pathway in cell-culture models, upregulating SOD1, catalase, and glutathione peroxidase. It has also been shown to suppress NF-κB-mediated pro-inflammatory cytokine expression (IL-6, TNF-α, IL-1β) in LPS-stimulated macrophage models.

DNA-repair stimulation: gene-expression profiling (Pickart and colleagues) documented upregulation of multiple DNA-repair pathways (nucleotide-excision, base-excision) in human dermal fibroblasts exposed to GHK-Cu — suggesting a broader cytoprotective role beyond ECM remodelling.

Research background and peer-reviewed literature

The foundational characterisation was published by Pickart and Thaler (1973) in Nature New Biology, identifying GHK as a plasma-albumin-derived peptide with growth-promoting activity on hepatocytes in culture. Maquart et al. published seminal research documenting GHK-Cu’s regulation of collagen and ECM gene expression in human fibroblasts. Poole et al. characterised GHK-Cu’s angiogenic properties in in-vitro and in-vivo assays.

A comprehensive gene-expression analysis by Pickart et al. in Organogenesis (2012) profiled genome-wide transcriptional responses to GHK-Cu in human dermal fibroblasts, documenting upregulation of 327 genes including ECM components, growth factors, antioxidant enzymes, and DNA-repair genes — providing a systems-level view that has guided subsequent targeted mechanistic research.

Reconstitution and storage protocol

1. GHK-Cu dissolves readily in water. Reconstitute in sterile distilled water or PBS at the desired research concentration.
2. Typical working concentrations: 1 nM to 10 μM; dose-response studies commonly use 0.01–100 μM.
3. GHK-Cu solution should be blue; colourless solution suggests copper dissociation. If colourless, check pH (optimal Cu²⁺ chelation at pH 6–8) and consider re-chelation with equimolar CuSO₄ if needed.
4. Filter through 0.22 μm for sterile cell-culture applications.

Storage: lyophilized at −20 °C, sealed, desiccated, light-protected (stable 24+ months). Reconstituted at 4 °C for up to 28 days, protected from light. Avoid EDTA-containing storage buffers and very alkaline pH — both promote copper loss.